Autres langues Pacific Biosciences of California, Inc. Boerse Muenchen

Actions

P09

US69404D1081

Equipement et technologie médicale avancés

Temps réel Boerse Muenchen 16:36:08 06/10/2026			Varia. 5j.	Varia. 1 janv.
2,322 ^EUR	-10,38%		+57,89%	+51,49%

15:57	Pacific Biosciences of California et TychoBio collaborent pour produire des données d’ARN pleine longueur destinées à l’entraînement de modèles d’IA	MT
16/09	Transcript : Pacific Biosciences of California, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 04:50 PM

Autres langues

15:57	Pacific Biosciences of California, TychoBio Collaborate to Generate Full-Length RNA Data for AI Model Training
15:06	PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics
04/09	PacBio to Participate in the Morgan Stanley 24?? Annual Global Healthcare Conference
03/09	PacBio to Participate in the Morgan Stanley 24ᵗʰ Annual Global Healthcare Conference
05/08	Pacific Biosciences: Q2 Earnings Snapshot
05/08	Pacific Biosciences Announces Restructuring Plan, Cutting 8% of Workforce to Drive Up to $40 Million in Annual Savings by 2027
05/08	Pacific Biosciences of California, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
05/08	PacBio Announces Second Quarter 2026 Financial Results
05/08	PacBio Appoints Mark Van Oene as President and Chief Executive Officer
05/08	Pacific Biosciences of California, Inc. Announces CEO Changes, Effective August 5, 2026
05/08	Pacific Biosciences of California, Inc. Announces President Changes, Effective August 5, 2026
05/08	Pacific Biosciences of California, Inc. Provides Revenue Guidance for the Full Year of 2026
05/08	PacBio Announces Availability Of SPRQ-Nx Chemistry And Software Update For Vega System
05/08	PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system
28/07	PacBio to Participate in the Canaccord Genuity 46th Annual Growth Conference
15/07	PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026
09/07	Pacific Biosciences of California, Inc. Announces Resignation of Christopher M. Smith from Director, Effective July 8, 2026
29/06	Pacific Biosciences of California, Inc.(NasdaqGS:PACB) added to Russell Small Cap Comp Growth Benchmark
29/06	Pacific Biosciences of California, Inc.(NasdaqGS:PACB) added to Russell 2500 Growth Benchmark
29/06	Pacific Biosciences of California, Inc.(NasdaqGS:PACB) added to Russell 2000 Growth Benchmark
29/06	Pacific Biosciences of California, Inc.(NasdaqGS:PACB) added to Russell 3000E Growth Benchmark
29/06	Pacific Biosciences of California, Inc.(NasdaqGS:PACB) added to Russell 3000 Growth Benchmark
26/05	Pacbio Ships Sprq-Nx Chemistry and Multi-Use Smrt Cells for Revio Hifi Sequencing Platform Worldwide
26/05	PacBio SPRQ-Nx Chemistry Now Shipping Worldwide, Enabling Sub-$300 HiFi Genomes for Large Scale Projects and AI-Enhanced Sequencing
21/05	PacBio to Participate in the Jefferies Global Healthcare Conference